Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-08-06

FDA Approved: FAMOTIDINE — Original Application (Novadoz Pharmaceuticals LLC)

View source ↗

Summary

FDA approved the original ANDA application for famotidine from Novadoz Pharmaceuticals LLC, enabling a generic version of famotidine to reach the market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Famotidine (famotidine)

Snippet

ORIG AP for FAMOTIDINE (FAMOTIDINE)